Eli Lilly Partners with Blacksmith Medicines in $300mn Seed Funding Deal

Fundamentals Eli Lily

For this year the company, based inIndianapolis revenue will be around 24,39 billion USD. This is according to the average of the analysts' estimates. This is slightly more than 2019's revenue of 22,32 billion USD.

Historical revenues and results Eli Lilly plus estimates 2020

The analysts expect for 2020 a net profit of 6,89 billion USD. For this year the consensus of Eli Lilly's result per share is a profit of 7,52 USD. The price/earnings-ratio is then 24,73.

Per share the analysts anticipate on a dividend of 2,99 USD per share. Eli Lilly's dividend yield thus equals 1,61 percent. The average dividend yield of the pharmaceutical companies equals a low 0,16 percent.

Eli Lilly's market capitalization is based on the number of outstanding shares around 196,66 billion USD. The Eli Lilly stock was the past 12 months quite volatile. Since last January the stock is even 37 percent higher. This year the stock price moved between 117 and 189 dollar.

Historical stock prices Eli Lilly

Click here for dividend Eli Lilly. At 21.32 the stock trades 4,13 percent lower at 185,94 USD.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.